Cargando…

Has the door closed on hydroxychloroquine for SARS-COV-2?

Detalles Bibliográficos
Autor principal:	Paul, Mical
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573573/ https://www.ncbi.nlm.nih.gov/pubmed/33096242 http://dx.doi.org/10.1016/j.cmi.2020.10.011

Ejemplares similares

HIV Transmission: Closing All the Doors
por: Davis, Carl W., et al.
Publicado: (2004)

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

Commentary: Do not close a door that opens a window!
por: Giambuzzi, Ilaria, et al.
Publicado: (2021)

Closing gaps, opening doors: an experimental collaboration in stem cell intervention
por: Rossi, Fabio, et al.
Publicado: (2020)

The Closed Door
Publicado: (1905)

When all doors close: Implications of COVID-19 for cosmopolitan entrepreneurs
por: Nummela, Niina, et al.
Publicado: (2020)

Closing the doors of the ALICE magnet
por: Brice, Maximillien
Publicado: (2021)

Closing the Door on Quantum Nonlocality
por: Kupczynski, Marian
Publicado: (2018)

Oestrogen shuts the door on SOX9
por: Mork, Lindsey, et al.
Publicado: (2010)

Toll-like receptors: the key to the stable door?
por: Hopkins, Philip, et al.
Publicado: (2002)

Many Keys Unlock the Doors for Virus Entry
por: Gallagher, Tom
Publicado: (2022)

Panbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care
por: Bulilete, Oana, et al.
Publicado: (2021)

Hyperglycémie, hydroxychloroquine et SARS-CoV-2
por: Ilias, Ioannis, et al.
Publicado: (2021)

FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
por: Symeonides, Stefan N., et al.
Publicado: (2017)

Revolving doors and conflicts of interest in health regulatory agencies in Brazil
por: Scheffer, Mário C, et al.
Publicado: (2020)

Repurposed drugs for COVID-19: threshold and proof requirements for trials
por: Paul, Mical, et al.
Publicado: (2021)

ALICE doors opening closing during LS2 in 2020
por: Brice, Maximilien
Publicado: (2020)

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
por: Mudgal, Rajat, et al.
Publicado: (2020)

Open the intensive care unit doors to HIV-infected patients with sepsis
por: Timsit, Jean-François
Publicado: (2005)

Does hydroxychloroquine reduce mortality for COVID-19?
por: GALLUS, Silvano, et al.
Publicado: (2020)

Hydroxychloroquine for COVID-19: Balancing contrasting claims
por: Horby, Peter W., et al.
Publicado: (2020)

Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
por: Hennekens, Charles H., et al.
Publicado: (2022)

Hydroxychloroquine screening in the UK-closing the gaps
por: Gobbett, Anne
Publicado: (2021)

View of the ALICE detector with its magnet doors closed
por: Hertzog, Samuel Joseph
Publicado: (2021)

Gastric Deserosalization: What Lies Behind Closed Doors
por: Goel, Prabudh, et al.
Publicado: (2018)

The atrial fibrillation epidemic is approaching the physician’s door: will mobile technology improve detection?
por: Lindsberg, Perttu J, et al.
Publicado: (2014)

Keeping the front door open: ensuring access to primary care for all in Canada
por: Kiran, Tara
Publicado: (2022)

The one-dose schedule opens the door to rapid scale-up of HPV vaccination
por: Zou, Zhuoru, et al.
Publicado: (2023)

Structural biology of SARS-CoV-2: open the door for novel therapies
por: Yan, Weizhu, et al.
Publicado: (2022)

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
por: Kaptein, Suzanne J. F., et al.
Publicado: (2020)

Mass testing for COVID-19 in Ulaanbaatar, Mongolia: “One door-one test” approach
por: Dorjdagva, Javkhlanbayar, et al.
Publicado: (2021)

Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load
por: Nguyen, Tuan V.
Publicado: (2021)

Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection
por: Yadav, Reetika Malik, et al.
Publicado: (2021)

Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)?
por: Wright, Christopher, et al.
Publicado: (2020)

Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
por: Yuan, Zixuan, et al.
Publicado: (2020)

Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: de Miranda Santos, Isabel Kinney Ferreira, et al.
Publicado: (2020)

First evaluation of hydroxychloroquine recommendations in treating SARS-CoV-2
por: Roussel, Y., et al.
Publicado: (2020)

Hybrid Procedures. Opening Doors for Surgeon and Cardiologist Close Collaboration
por: Gil-Jaurena, Juan-Miguel, et al.
Publicado: (2021)

LS1 Report: As one door closes, another opens
por: Katarina Anthony & Anaïs Schaeffer
Publicado: (2014)

Opening the Door to Zero New HIV Infections in Closed Settings
por: Torriente, Anna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2btajoh2hdo41ev2i1cof1goe0